updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
Published 2 years ago • 505 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
4:25
update on momelotinib for myelofibrosis
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:01
clinical outcomes for patients with myelofibrosis after transition from ruxolitinib to momelotinib
-
4:09
myelofibrosis (rare blood cancer): what are the first symptoms? | the patient story
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
3:19
first-line treatment selection in myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
1:24
updated results from the momentum study assessing the efficacy of momelotinib in mf
-
1:15
ongoing trials of ruxolitinib, momelotinib and imetelstat in myelofibrosis
-
5:12
ongoing clinical trials of ruxolitinib-based combinations in myelofibrosis
-
2:48
updated results from the momentum trial
-
1:01
latest advances in myelofibrosis treatment
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:40
momelotinib for the treatment of myelofibrosis
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:35
analysis from most: disease progression and leukemic transformation in lower-risk myelofibrosis
-
1:52
an update on the use of navtemadlin in myelofibrosis
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct